Obesity, Pregnancy, Pregnancy Complications
Conditions
Interventions
This is a randomized clinical trial, using omega-3, which will be developed with obese pregnant women who will be randomized into 2 groups, a study group that will use omega-3 and standard monitoring,
Dietary supplement
Sponsors
Universidade da Região de Joinville - UNIVILLE
Maternidade Darcy Vargas
Eligibility
Sex/Gender
Female
Age
18 Years to 45 Years
Inclusion criteria
Inclusion criteria: Pregnant women diagnosed with obesity will be selected according to World Health Organization criteria with a BMI greater than or equal to 30 kg / m2, aged 18 years or over, single pregnancy, with negative screening for gestational diabetes mellitus (GDM) at the beginning of pregnancy, gestational age less than 20 weeks, without pathology that interferes with glucose metabolism, coagulation disorder, systemic arterial hypertension (SAH), history or presence of liver, kidney or gastrointestinal disease or other condition that interferes with absorption, distribution and excretion of omega-3.
Exclusion criteria
Exclusion criteria: Pregnant women who wish to do so and those who are at risk for the fetus will be excluded.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Positive and significant effect of omega-3 in the prevention of Gestational Diabetes Mellitus in obese pregnant women, verified through the presence of difference in the incidence of Gestational Diabetes Mellitus between the groups, from the verification of a p value less than or equal to 0,05 in the comparison between groups for this outcome.;Positive and significant effect of omega-3 in the prevention of Specific Hypertensive Disease of Pregnancy in obese pregnant women, verified through the presence of difference in the incidence of Specific Hypertensive Disease of Pregnancy between the groups, from the verification of a value of p less or equal to 0.05 in the comparison between groups for this outcome.;Positive and significant effect of omega-3 on the lipid profile of obese pregnant women, verified through the presence of a difference in lipid profile between the groups, from the finding of a p value less than or equal to 0.05 in the comparison between the groups for this outcome.;Positive and significant effect of omega-3 on the cesarean section rate of obese pregnant women, verified through the presence of difference in the need for cesarean sections between the groups in absolute number and proportion, from the finding of a p value less than or equal to 0 , 05 in the comparison between groups for this outcome.;Positive and significant effect of omega-3 on the number of GIGs of obese pregnant women, verified through the presence of a difference in the incidence of newborns GIGs between the groups, from the finding of a p value less than or equal to 0.05 in the comparison between groups for this outcome.;Positive and significant effect of omega-3 on the platelet count of obese pregnant women verified by the presence of difference in the platelet count between the groups, from the finding of a p value less than or equal to 0.05 in the comparison between the groups for the east outcome. | — |
Secondary
| Measure | Time frame |
|---|---|
| There are no secondary outcomes | — |
Countries
Brazil
Contacts
Public ContactGuilherme Dienstmann
Universidade da Região de Joinville - UNIVILLE
Outcome results
None listed